Niu Yanyan, Li Sensen, Lin Zongtao, Liu Meixian, Wang Daidong, Wang Hong, Chen Shizhong
School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, United States.
J Chromatogr A. 2016 Sep 9;1463:102-9. doi: 10.1016/j.chroma.2016.08.013. Epub 2016 Aug 8.
Fufang Banbianlian Injection (FBI) has been widely used as an anti-inflammatory and anti-tumor prescription. To understand the relationships between its bioactive ingredients and pharmacological efficacies, our previous study has been successfully identified some DNA-binding compounds in FBI using an established on-line screening system, in which 4',6-diamidino-2-phenylindole (DAPI) was developed as a probe. However, DAPI can be only used to screen ATT-specific DNA minor groove binders, leaving the potential active intercalators unknown in FBI. As a continuation of our studies on FBI, here we present a sensitive analytical method for rapid identification and evaluation of DNA-intercalators using propidium iodide (PI) as a fluorescent probe. We have firstly established the technique of high-performance liquid chromatography-diode-array detector-multistage mass spectrometry-deoxyribonucleic acid-propidium iodide-fluorescence detector (HPLC-DAD-MS(n)-DNA-PI-FLD) system. As a result, 38 of 58 previously identified compounds in FBI were DNA-intercalation active. Interestingly, all previously reported DNA-binders also showed intercalative activities, suggesting they are dual-mode DNA-binders. Quantitative study showed that flavonoid glycosides and chlorogenic acids were the main active compounds in FBI, and displayed similar DNA-binding ability using either DAPI or PI. In addition, 13 active compounds were used to establish the structure-activity relationships. In this study, PI was developed into an on-line method for identifying DNA-intercalators for the first time, and thus it will be a useful high-throughput screening technique for other related samples.
复方半边莲注射液(FBI)已被广泛用作抗炎和抗肿瘤的处方。为了解其生物活性成分与药理功效之间的关系,我们之前的研究利用已建立的在线筛选系统成功鉴定出FBI中的一些DNA结合化合物,其中4',6-二脒基-2-苯基吲哚(DAPI)被开发为探针。然而,DAPI仅可用于筛选特异性结合ATT的DNA小沟结合剂,FBI中潜在的活性嵌入剂仍未知。作为我们对FBI研究的延续,在此我们提出一种灵敏的分析方法,以碘化丙啶(PI)作为荧光探针快速鉴定和评估DNA嵌入剂。我们首先建立了高效液相色谱-二极管阵列检测器-多级质谱-脱氧核糖核酸-碘化丙啶-荧光检测器(HPLC-DAD-MS(n)-DNA-PI-FLD)系统。结果显示,FBI中先前鉴定的58种化合物中有38种具有DNA嵌入活性。有趣的是,所有先前报道的DNA结合剂也显示出嵌入活性,表明它们是双模式DNA结合剂。定量研究表明,黄酮苷和绿原酸是FBI中的主要活性化合物,使用DAPI或PI时表现出相似的DNA结合能力。此外,利用13种活性化合物建立了构效关系。在本研究中,PI首次被开发成一种用于鉴定DNA嵌入剂的在线方法,因此它将成为一种用于其他相关样品的有用的高通量筛选技术。